Diagnosed in thousands of American men each year, testicular cancer has proven highly sensitive to current treatment regimens. Host Dr. Mark Nolan Hill evaluates the most common therapies for testicular cancer with Dr. Craig Nichols, medical director of lymphoma and testicular cancer research at Providence Portland Medical Center in Portland, Ore., and an internationally respected expert on testicular cancer. Are there significant side effects to the present therapies? Further, keeping in mind the possibility of a recurrent disease, and the accordant need for proper follow-up measures, Dr. Nichols evaluates strategies for coordinating care between medical oncologists and primary care physicians.
Testicular Cancer: Raising Already Lofty Cure Rates
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
Diagnosed in thousands of American men each year, testicular cancer has proven highly sensitive to current treatment regimens. Host Dr. Mark Nolan Hill evaluates the most common therapies for testicular cancer with Dr. Craig Nichols, medical director of lymphoma and testicular cancer research at Providence Portland Medical Center in Portland, Ore., and an internationally respected expert on testicular cancer. Are there significant side effects to the present therapies? Further, keeping in mind the possibility of a recurrent disease, and the accordant need for proper follow-up measures, Dr. Nichols evaluates strategies for coordinating care between medical oncologists and primary care physicians.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?